APGE
Apogee Therapeutics Earnings
$47.71
Earnings Summary
Revenue | $0Mn |
Net Profits | $-49.02Mn |
Net Profit Margins | -Inf% |
Apogee Therapeutics’s revenue jumped NaN% since last year same period to $0Mn in the Q3 2024. On a quarterly growth basis, Apogee Therapeutics has generated NaN% jump in its revenue since last 3-months.
Apogee Therapeutics’s net profit fell -135.21% since last year same period to $-49.02Mn in the Q3 2024. On a quarterly growth basis, Apogee Therapeutics has generated -44.96% fall in its net profits since last 3-months.
Apogee Therapeutics’s net profit margin jumped NaN% since last year same period to -Inf% in the Q3 2024. On a quarterly growth basis, Apogee Therapeutics has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Apogee Therapeutics post its latest quarter earningsEPS Estimate Current Quarter | -0.74 |
EPS Estimate Current Year | -0.74 |
Apogee Therapeutics’s earning per share (EPS) estimates for the current quarter stand at -0.74 - a -34.55% fall from last quarter’s estimates.
Apogee Therapeutics’s earning per share (EPS) estimates for the current year stand at -0.74.
Key Ratios
Key ratios of the Apogee Therapeutics post its Q3 2024 earningsEarning Per Share (EPS) | -0.86 |
Apogee Therapeutics’s earning per share (EPS) fell -68.63% since last year same period to -0.86 in the Q3 2024. This indicates that the Apogee Therapeutics has generated -68.63% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-11-12 | -0.74 | -0.86 | -16.22% |
2024-05-13 | -0.61 | -0.64 | -4.92% |
2024-08-12 | -0.55 | -0.6 | -9.09% |
₹0 US Stocks a/c Opening Fee